Home
>
Funded Research
>
Search Grant Database
>
Research by Grant Title
Title,
Institution
Award Cycle,
Investigator
Award
[
sort
]
(-) Lobeline: total synthesis and derivitization
2002 (Cycle XI)
$60,000
California Institute of Technology
Jeffrey Bagdanoff
B.S.
11DT-0193
11th National Conference on Nicotine Dependence
1998 (Cycle VII)
$12,000
American Society of Addiction Medicine
Lori Karan
M.D.
7ST-0198
16S rRNA PhyloChip Analysis of Bacterial Communities in COPD
2008 (Cycle XVII)
$75,000
University of California, San Francisco
Yvonne Huang
M.D.
17FT-0040
2nd East West Conference on Tobacco and Alcohol
2005 (Cycle XIV)
$15,000
University of Southern California
Andy Johnson
14ST-0190
2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth
1995 (Cycle IV)
$149,221
The Burnham Institute for Medical Research
Hudson Freeze
Ph.D.
4IT-0225
50000 Fold Signal Enhancement for Imaging Vulnerable Plaque
2007 (Cycle XVI)
$213,845
Huntington Medical Research Institute
Pratip Bhattacharya
Ph.D.
16KT-0044
A dynamic model of smoking and healthcare expenditures in CA
2000 (Cycle IX)
$595,843
University of California, San Francisco
Wendy Max
Ph.D.
9RT-0157
A longitudinal study of smoking transitions in youth
1999 (Cycle VIII)
$577,574
University of California, San Diego
Elizabeth Gilpin
M.S.
8RT-0086
A Methodological Multi-Ethnic Study of Smoking Initiation
1995 (Cycle IV)
$260,978
University of California, Los Angeles
Celia Kaplan
DrPH
4RT-0257
A mindfulness-based approach to relapse prevention
2005 (Cycle XIV)
$134,325
California Pacific Medical Center Research Institute
Cassandra Vieten
Ph.D.
14IT-0178
A model system for smoking-related damage to proteins
1999 (Cycle VIII)
$75,375
J. David Gladstone Institutes
Johan Bjorkegren
M.D., Ph.D.
8FT-0022
A New Approach for Studying the Mechanism of Squamous Metapl
1995 (Cycle IV)
$75,000
University of California, Los Angeles
Sanford Barsky
M.D.
4IT-0328
A new molecular approach for predicting lung cancer
2000 (Cycle IX)
$75,000
University of California, Irvine
Ram Kumar Sindhu
Ph.D.
9IT-0121
A novel approach to prevent in utero nicotine lung injury
2005 (Cycle XIV)
$597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
14RT-0073
A Novel Approach to Prevent in Utero Nicotine Lung Injury
2008 (Cycle XVII)
$564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
17RT-0170
A novel FMRI smoking craving and reward paradigm
2003 (Cycle XII)
$96,949
University of California, Los Angeles
John Monterosso
Ph.D.
12IT-0198
A novel lung tumor suppressor
1997 (Cycle VI)
$144,788
The Burnham Institute for Medical Research
Steven Frisch
Ph.D.
6IT-0128
A novel therapeutic target for stroke
1997 (Cycle VI)
$72,310
The Burnham Institute for Medical Research
Li-Tao Zhong
M.D., Ph.D.
6FT-0157
A novel total synthesis of brazilin and brazilide A
2005 (Cycle XIV)
$59,191
University of California, Santa Barbara
Yaodong Huang
M.S.
14DT-0130
A novel, 3-dimensional approach to non-invasive diagnostics
2005 (Cycle XIV)
$99,000
University of California, Irvine
Petra Wilder-Smith
D.D.S., Ph.D.
14IT-0097
A retroviral link to human tobacco-related lung cancer?
1999 (Cycle VIII)
$74,500
University of California, Los Angeles
Sanford Barsky
M.D.
8IT-0046
A Smokeless Tobacco Cessation Program: High School Athletes
1995 (Cycle IV)
$533,923
University of California, San Francisco
Margaret Walsh
MS, EdD
4RT-0068
A stage-based scheduled smoking intervention for Chinese
2005 (Cycle XIV)
$554,500
University of California, San Francisco
Janice Tsoh
Ph.D.
14RT-0160H
A study of Bax, a gene involved in killing tumor cells
1998 (Cycle VII)
$75,060
The Burnham Institute for Medical Research
Shahrzad Nouraini
Ph.D.
7FT-0100
A web-based support community as a tool for ST cessation
2003 (Cycle XII)
$100,000
University of California, San Francisco
Margaret Walsh
MS, EdD
12IT-0169
Acculturation & cigarette smoking among Asian-Americans
1997 (Cycle VI)
$244,715
University of Southern California
Xinguang Chen
Ph.D.
6KT-0191
Acculturation, media, peers, parents and adolescent smoking
1998 (Cycle VII)
$213,511
University of Southern California
Jennifer Unger
Ph.D.
7PT-7004H
Activation and detoxification of lung cancer carcinogens
2006 (Cycle XV)
$420,000
University of California, San Diego
Robert Tukey
Ph.D.
15RT-0251
Activation of Bnip3 in tobacco-induced heart disease
2005 (Cycle XIV)
$134,074
Scripps Research Institute
Asa Gustafsson
Ph.D.
14KT-0109
Activation of Bnip3 in tobacco-induced heart disease
2005 (Cycle XIV)
$155,791
San Diego State University Research Foundation
Asa Gustafsson
Ph.D.
14KT-0109A
Activation of NF-kB by cigarette smoke
1999 (Cycle VIII)
$224,217
University of California, Davis
Richart Harper
M.D.
8KT-0092
Ad and Movie Imagery and Teen's Perceptions About Smokers
1995 (Cycle IV)
$190,616
University of California, Irvine
Cornelia Pechmann
Ph.D.
4RT-0082
Addressing Substance Abusers Who Also Smoke
1994 (Cycle III)
$270,931
Northern California Institute for Research & Education
Karen Sees
D.O.
3KT-0121
Adolescent susceptibility to tobacco: a panel analysis
2001 (Cycle X)
$495,433
University of California, Irvine
Larry Jamner
Ph.D.
10RT-0255
Adolescent Susceptibility to Tobacco: A Panel Analysis
1997 (Cycle VI)
$456,076
University of California, Irvine
Larry Jamner
Ph.D.
6PT-3003H
African American church role in tobacco norm change
2005 (Cycle XIV)
$115,098
Health Education Council
Ayanna Kiburi
MPH
14IT-0188
African Americans and Mentholated Cigarettes
1999 (Cycle VIII)
$417,968
Charles R. Drew University of Medicine & Science
Bruce Allen
DrPH
8RT-0091H
African Americans: NRT or Alternative Medicine for Cessation
2006 (Cycle XV)
$285,000
University of California, San Francisco
Valerie Yerger
ND, MA
15KT-0038H
Aggression and Nicotine
1997 (Cycle VI)
$230,326
University of California, Irvine
Larry Jamner
Ph.D.
6RT-0154
Airway transcriptome changes in smokers
2004 (Cycle XIII)
$99,500
University of California, San Francisco
John Fahy
M.D.
13IT-0097
ALAC 2003 Annual Conference
2003 (Cycle XII)
$5,000
American Lung Association of California
Steve O'Kane
12ST-0264
ALAC Annual Conference
2005 (Cycle XIV)
$2,500
American Lung Association of California
Lynn Devine
14ST-0192
ALAC Annual Conference
2006 (Cycle XV)
$5,000
American Lung Association of California
Kerlyn Chatelain-Graham
15ST-0258
ALAC Annual Conference
2007 (Cycle XVI)
$5,000
American Lung Association of California
Laura Keegan
16ST-0217
ALAC Conference
2004 (Cycle XIII)
$5,000
American Lung Association of California
Laura Keegan
13ST-0175
Allocation of Health Care to Smokers: Practice and Ethics
1998 (Cycle VII)
$113,598
Stanford University
Thomas Raffin
M.D.
7IT-0129
Allosteric Protein Kinase Modulators via Disulfide Trapping
2008 (Cycle XVII)
$75,000
University of California, San Francisco
Jack Sadowsky
Ph.D.
17FT-0042
Alpha4* Nicotinic Receptor in Dopaminergic System
2007 (Cycle XVI)
$75,000
California Institute of Technology
Cheng Xiao
Ph.D.
16FT-0066
Alterations in gene expression after tobacco smoke exposure
1997 (Cycle VI)
$216,612
University of California, Davis
Ken Yoneda
M.D.
6KT-0016
Alternative sources of ETS exposure in infants
1998 (Cycle VII)
$109,687
San Diego State University Research Foundation
Georg Matt
Ph.D.
7IT-0087
An athletic trainer mediated spit tobacco cessation program
1998 (Cycle VII)
$490,546
University of California, San Francisco
Margaret Walsh
MS, EdD
7RT-0058
An economic analysis of factors influencing teen smoking
1998 (Cycle VII)
$221,497
University of California, San Diego
Sherry Emery
MBA, Ph.D.
7KT-0193
An RNA biomarker for tobacco smoke toxicity
1999 (Cycle VIII)
$51,751
University of California, Davis
Richard Kimura
8DT-0174
Anabolic therapies for muscle dysfunction in women with COPD
2001 (Cycle X)
$632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Richard Casaburi
M.D., Ph.D.
10RT-0046
Analysis of a candidate lung tumor suppressor gene at 3p21.3
2000 (Cycle IX)
$111,910
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
9RT-0175
Analysis of a lung tumor supressor gene at 3p21.3
2001 (Cycle X)
$249,438
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
10RT-0016
Analysis of a nicotine-related receptor binding site
1997 (Cycle VI)
$69,218
University of California, San Francisco
Laura England
Ph.D.
6FT-0103
Analysis of California adolescent tobacco data
2001 (Cycle X)
$475,742
University of California, Los Angeles
William McCarthy
Ph.D.
10RT-0333
Analysis of the Hippo pathway in lung cancer
2008 (Cycle XVII)
$654,999
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
17RT-0116
Analysis of tobacco industry documents on scientific researc
2000 (Cycle IX)
$442,646
University of California, San Francisco
Lisa Bero
Ph.D.
9RT-0193
Antiatherogenic helical segments of apo A-I
2004 (Cycle XIII)
$141,230
Lawrence Berkeley National Laboratory
John Bielicki
Ph.D.
13IT-0025
Antioxidants, cigarette smoking and atherosclerosis
1998 (Cycle VII)
$730,640
University of Southern California
James Dwyer
Ph.D.
7RT-0034
Antismoking slides in movie Theaters: A Naturalistic Eval
2000 (Cycle IX)
$10,000
University of California, Irvine
Cornelia Pechmann
Ph.D.
9ST-0244
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing
1997 (Cycle VI)
$446,947
University of California, Los Angeles
Barbara Berman
Ph.D.
6RT-0047
ApoE isoforms, fatty acid metabolism and atherosclerosis
2001 (Cycle X)
$691,616
J. David Gladstone Institutes
Robert Pitas
Ph.D.
10RT-0313
ApoE related effect of smoking in cardiovascular disease
2008 (Cycle XVII)
$630,561
Children's Hospital Oakland Research Institute
Vasanthy Narayanaswami
Ph.D.
17RT-0165
Apolipoprotein E: remnant metabolism and atherogenesis
1999 (Cycle VIII)
$793,474
J. David Gladstone Institutes
Yadong Huang
M.D., Ph.D.
8RT-0130
Ascertainment of environmental tobacco exposure in pregnancy
1999 (Cycle VIII)
$2,053,747
Sequoia Foundation
Martin Kharrazi
Ph.D.
8RT-0115
Asian American and Pacific Islander (AAPI) Sci. Conf./Wkshp.
2007 (Cycle XVI)
$5,000
University of California, Los Angeles
Yih-Ing Hser
Ph.D.
16ST-0214
Assessing nicotine relapse in a mouse model
2001 (Cycle X)
$183,804
SRI International
Taline Khroyan
Ph.D.
10KT-0007
Association of Outlet Density with Smoking and Pack Price
2008 (Cycle XVII)
$516,285
Stanford University
Lisa Henriksen
Ph.D.
17RT-0152
Asthma, gender, and ETS: pathogenic synergy
2005 (Cycle XIV)
$98,908
University of California, Davis
Laurel Gershwin
D.V.M., Ph.D.
14IT-0081
BAG-1, a unique gene involved in smoking-associated cancers
1998 (Cycle VII)
$75,060
The Burnham Institute for Medical Research
Zhihua Xie
Ph.D.
7FT-0092
Banning Butts: The Environmental Case
2008 (Cycle XVII)
$99,500
University of California, San Francisco
Thomas Novotny
M.D., MPH
17IT-0014
Bayview-Hunters Point partnership toward smoking cessation
2002 (Cycle XI)
$75,000
University of California, San Francisco
Carol McGruder
B.A.
11BT-1701
Bayview-Hunters Point partnership toward smoking cessation
2002 (Cycle XI)
$75,000
University of California, San Francisco
Ruth Malone
Ph.D., R.N.
11BT-1701
Behavioral effects of neonatal nicotine exposure
2000 (Cycle IX)
$624,780
San Diego State University Research Foundation
Edward Riley
Ph.D.
9RT-0012
Behavioral epidemiology of tobacco use among gay men
1998 (Cycle VII)
$626,433
University of California, San Francisco
Greg Greenwood
Ph.D.
7RT-0013
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro
1995 (Cycle IV)
$321,199
University of California, San Diego
Hyam Leffert
M.D.
4RT-0076
Bioactive lipids in tobacco related lung cancers
1997 (Cycle VI)
$74,496
University of California, San Diego
Jerold Chun
M.D., Ph.D.
6IT-0375
Birth defects, smoking and host susceptibility
2003 (Cycle XII)
$466,200
March of Dimes Birth Defects Foundation
Suzan Carmichael
Ph.D.
12RT-0098
Bispecific molecular therapy of small cell lung cancer
2001 (Cycle X)
$434,805
University of California, San Diego
Edward Ball
M.D.
10RT-0064
Boosting the immune response against lung cancer
1998 (Cycle VII)
$70,000
University of California, Los Angeles
Marina Stolina
Ph.D.
7FT-0035
Brachial Vasoreactivity in Young Adult Smokers
1997 (Cycle VI)
$332,294
Osteoporosis Medical Center
Jacques Barth
M.D., Ph.D.
6RT-0053
Brain adaptations to chronic nicotine expsoure
1997 (Cycle VI)
$402,111
University of California, Irvine
Frances Leslie
Ph.D.
6RT-0416
Brain imaging in nicotine addiction
2002 (Cycle XI)
$419,881
University of California, Los Angeles
Desmond Smith
Ph.D.
11RT-0172
Brain metabolic changes with cigarette craving
1998 (Cycle VII)
$250,850
Brentwood Biomedical Research Institute
Arthur Brody
M.D.
7KT-0098
Brain nAChR Occupancy: Effect of Secondhand Smoke
2007 (Cycle XVI)
$623,841
Brentwood Biomedical Research Institute
Arthur Brody
M.D.
16RT-0098
Brain wave assessment of tobacco cessation readiness
1997 (Cycle VI)
$115,487
Scripps Research Institute
Aaron Ilan
Ph.D.
6KT-0312
Bupropion and nicotine dependence: behavior & neurochemisty
2005 (Cycle XIV)
$37,500
Scripps Research Institute
Neil Paterson
B.Sc., MBCh.B.
14FT-0056
Bupropion and nicotine dependence: behavior & neurochemisty
2005 (Cycle XIV)
$37,000
University of California, San Diego
Neil Paterson
B.Sc., MBCh.B.
14FT-0056A
Bupropion for hospital-based smoking cessation
2003 (Cycle XII)
$478,065
University of California, San Francisco
Joel Simon
M.D., M.P.H.
12RT-0148
Bupropion for smoking cessation
1998 (Cycle VII)
$471,154
University of California, San Francisco
Joel Simon
M.D., M.P.H.
7RT-0033
California AB13 compliance and ethnicity in urban bars
2003 (Cycle XII)
$769,266
Pacific Institute for Research and Evaluation
Roland Moore
BA, MA, Ph.D.
12RT-0116
California pharm-assists for smoking cessation
1999 (Cycle VIII)
$124,689
SRI International
Karen Hudmon
Dr.P.H., R.P.H., M.S.
8BT-2301
California pharm-assists for smoking cessation
1999 (Cycle VIII)
$124,689
SRI International
Marilyn Shreve
R.Ph.
8BT-2301
Calorigenic and Atherogenic Effects of Smoking and Nicotine
1995 (Cycle IV)
$357,492
University of California, San Francisco
Marc Hellerstein
M.D., Ph.D.
4RT-0233
Cambodian research initiative
2003 (Cycle XII)
$106,456
California State University, Long Beach Foundation
Robert Friis
Ph.D.
12BT-2201
Cambodian research initiative
2003 (Cycle XII)
$106,456
California State University, Long Beach Foundation
Him Chhim
MS, MPA
12BT-2201
Carbon monoxide and the brain growth spurt
1998 (Cycle VII)
$464,268
University of California, Los Angeles
John Edmond
Ph.D.
7RT-0039
Carbon monoxide as a modulator of myocardial function
1999 (Cycle VIII)
$225,000
University of California, Davis
Ulrike Kreutzer
Ph.D.
8KT-0042
Cardiac ion channels and tobacco-related disease
2002 (Cycle XI)
$389,983
University of California, Santa Barbara
Carol Vandenberg
Ph.D.
11RT-0114
Cardiovascular responses through spinal nicotinic receptors
2001 (Cycle X)
$448,941
University of California, San Diego
Palmer Taylor
Ph.D.
10RT-0107
Cardiovascular responses to nicotine
1997 (Cycle VI)
$430,843
University of California, San Diego
Palmer Taylor
Ph.D.
6RT-0009
Case studies of indoor air regulations: role of research
1997 (Cycle VI)
$292,210
University of California, San Francisco
Lisa Bero
Ph.D.
6RT-0025
Cell adhesion at nicotinic synapses
2005 (Cycle XIV)
$59,454
University of California, San Diego
Gallen Triana-Balzer
B.A.
14DT-0092
Cell-cell interact reg distrib of nic receptrs on neurons
2000 (Cycle IX)
$29,754
University of California, San Diego
Sergio Kaiser
9FT-0021
Cellular Defects in Lung caused by Tobacco Smoke
1995 (Cycle IV)
$319,013
University of California, San Francisco
Alan Verkman
M.D., Ph.D.
4RT-0072
cGMP regulation of vascular smooth muscle differentiation
2005 (Cycle XIV)
$403,818
University of California, San Diego
Renate Pilz
M.D.
14RT-0020
Chemical synthesis of communesin B, a novel antineoplastic
2005 (Cycle XIV)
$74,403
California Institute of Technology
Shyam Krishnan
Ph.D.
14FT-0002
Chemokine-based therapy for lung cancer
2001 (Cycle X)
$416,940
University of California, Los Angeles
Sherven Sharma
Ph.D.
10RT-0053
Chemopreventive strategies against lung cancer recurrence
2000 (Cycle IX)
$75,000
University of California, Los Angeles
Jenny Mao
M.D.
9IT-0023
Chemotherapeutic inhibition of polysialic acid biosynthesis
2003 (Cycle XII)
$420,781
University of California, Davis
Jacquelyn Gervay-Hague
Ph.D.
12RT-0254H
Cholesterol metabolism and atherosclerosis
1997 (Cycle VI)
$74,500
University of California, San Diego
Oswald Quehenberger
Ph.D.
6IT-0133
Chromatin Remodeling in Glucocorticoid Resistance of COPD
2008 (Cycle XVII)
$60,000
University of California, San Francisco
Karin Buser
B.S.
17DT-0177
Chronic bronchitis: pathology of mucin gene expression
2000 (Cycle IX)
$329,481
University of California, Davis
Walter Finkbeiner
M.D., Ph.D.
9RT-0214
Chronic bronchitis: pathology of mucin gene expression
2000 (Cycle IX)
$147,758
University of California, San Francisco
Walter Finkbeiner
M.D., Ph.D.
9RT-0214A
Chronic CO exposure impairs the developing auditory system
2004 (Cycle XIII)
$75,000
University of California, Los Angeles
Douglas Webber
Ph.D.
13FT-0150
Chronic nicotine treatment in primates; role of a6b2 nAChRs
2008 (Cycle XVII)
$577,128
The Parkinson's Institute
Maryka Quik
Ph.D.
17RT-0119
Cigar smoking among young adults: formative research
1997 (Cycle VI)
$292,920
California State University, Long Beach Foundation
Fen Rhodes
Ph.D.
6RT-0426
Cigar use prevalence: social and media determinants
1997 (Cycle VI)
$318,750
San Diego State University Research Foundation
Joachim Reimann
Ph.D.
6KT-0117
Cigarette smoke alters lipoprotein & artery wall interaction
1997 (Cycle VI)
$472,876
University of California, Los Angeles
Alan Fogelman
M.D.
6RT-0006
Cigarette smoke effects on cells crucial for wound healing
2001 (Cycle X)
$74,500
University of California, Riverside
Manuela Martins-Green
Ph.D.
10IT-0170
Cigarette smoke effects on human vascular endothelial genes
1998 (Cycle VII)
$75,000
University of California, Riverside
Craig Byus
Ph.D.
7IT-0173
Cigarette smoke injures lung epithelium by activating nSMase
2008 (Cycle XVII)
$394,380
University of California, Davis
Tzipora Goldkorn
BSc, MSc, Ph.D.
17RT-0131
Cigarette smoke, MCP-1 expression in vivo and atherogenesis
2002 (Cycle XI)
$50,418
University of California, Riverside
Lina Seang Wong
B.S.
11DT-0244
Cigarette Smoking and Stress-Coping among Latino Youth
2008 (Cycle XVII)
$60,000
University of Southern California
Rachel Grana
M.P.H.
17DT-0190
Cigarette smoking in HIV-positive populations
2000 (Cycle IX)
$74,882
University of California, San Francisco
Gary Humfleet
Ph.D.
9IT-0234
Classroom animation tobacco awareness program effectiveness
2004 (Cycle XIII)
$558,761
WestEd
Barbara Dietsch
Ph.D.
13HT-3201
Classroom animation tobacco awareness program effectiveness
2004 (Cycle XIII)
$558,761
WestEd
Diane Schwartz
M.A.
13HT-3201
Clearing the Air: An Institute for Policy Advocacy, IV
2007 (Cycle XVI)
$5,000
American Nonsmokers' Rights Foundation
Cynthia Hallett
MPH
16ST-0215
Clearing the Air: An Institute for Policy Advocacy, V
2007 (Cycle XVI)
$5,000
American Nonsmokers' Rights Foundation
Cynthia Hallett
MPH
16ST-0221
Clinical Pharmacology of Tobacco Alkaloids
2006 (Cycle XV)
$508,848
University of California, San Francisco
Peyton Jacob
Ph.D.
15RT-0181
Clinical pharmacology of tobacco alkaloids
2001 (Cycle X)
$373,408
University of California, San Francisco
Peyton Jacob
Ph.D.
10RT-0215
Clinical Pharmacology of Tobacco Alkaloids
1995 (Cycle IV)
$393,855
University of California, San Francisco
Peyton Jacob
Ph.D.
4RT-0023
Clinical pharmacology of tobacco alkaloids
1998 (Cycle VII)
$439,882
University of California, San Francisco
Peyton Jacob
Ph.D.
7RT-0104
Cloning & Expression of the Apo-B mRNA Editing Factor
1994 (Cycle III)
$254,743
J. David Gladstone Institutes
Thomas Innerarity
Ph.D.
3RT-0404
Cloning of a Lung Tumor Transport Gene for Drug Development
1995 (Cycle IV)
$104,966
University of California, San Diego
Michael Kelner
M.D., M.S.
4IT-0194
Cognitive effects of gestational nicotine
2004 (Cycle XIII)
$60,000
University of California, Irvine
Shahrdad Lotfipour
Ph.D.
13DT-0033
Community and Family Context of Teen Smoking
2008 (Cycle XVII)
$270,000
University of California, Los Angeles
Ritesh Mistry
Ph.D. M.P.A.
17KT-0030
Comprehensive evaluation of the ischemic leg
2000 (Cycle IX)
$672,390
Stanford University
Dwight Nishimura
Ph.D.
9RT-0024
Comprehensive Tobacco Policy Model
1997 (Cycle VI)
$439,963
University of California, Irvine
Tammy Tengs
Sc.D.
6PT-3005
Computer Simulation as a Tool for Reducing SHS Exposure
2007 (Cycle XVI)
$118,418
Education Training and Research Associates, Inc.
Neil Klepeis
16IT-0209
Conformationally constrained nicotine vaccines
2005 (Cycle XIV)
$778,921
Scripps Research Institute
Kim Janda
Ph.D.
14RT-0110
Context & consequenes of smoking in a blue-collar cohort
2005 (Cycle XIV)
$426,555
Pacific Institute for Research and Evaluation
Carol Cunradi
Ph.D., M.P.H.
14RT-0116
Contributions of CNRs to nicotinic signaling
2001 (Cycle X)
$70,000
University of California, San Diego
Martina Blank
Ph.D.
10FT-0235
Control of Mucociliary Clearance in the Respiratory Tract
1995 (Cycle IV)
$276,780
University of California, Los Angeles
Ellen Dirksen
Ph.D.
4RT-0079
Controlled study of withdrawal symptoms in teen smokers
2003 (Cycle XII)
$499,890
Stanford University
Joel Killen
Ph.D.
12RT-0141
COPD: oxygen transport and metabolism in skeletal muscle
2001 (Cycle X)
$224,500
University of California, San Diego
Luke Haseler
Ph.D.
10KT-0335
Co-regulator mechanisms in lung cancer
1999 (Cycle VIII)
$38,267
University of California, San Diego
Bogi Andersen
M.D.
8IT-0039
Corporate strategies: design, conduct, publication of resrch
2004 (Cycle XIII)
$407,567
University of California, San Francisco
Lisa Bero
Ph.D.
13RT-0108H
Correlates of cigarette craving in acute nicotine withdrawal
2003 (Cycle XII)
$17,000
University of California, Los Angeles
Murray Jarvik
M.D., Ph.D.
12RT-0132
Correlates of cigarette craving in acute nicotine withdrawal
2003 (Cycle XII)
$517,818
Brentwood Biomedical Research Institute
Richard Olmstead
Ph.D.
12RT-0132AH
Cotinine Metabolism in Infants and Children
2006 (Cycle XV)
$509,473
University of California, San Francisco
Neal Benowitz
M.D.
15RT-0229
COX-2 regulation of vaccination responses in lung cancer
2004 (Cycle XIII)
$379,362
University of California, Los Angeles
Steven Dubinett
M.D.
13RT-0031
COX-2-dependent modulation of survivin in lung cancer
2003 (Cycle XII)
$69,500
University of California, Los Angeles
Kostyantyn Krysan
Ph.D.
12FT-0061
CSF biomarkers of brain metastases from lung cancer
2003 (Cycle XII)
$100,000
University of California, San Francisco
James Rubenstein
M.D., Ph.D.
12IT-0246
CT imaging to assist diagnosis of solitary pulmonary nodules
2000 (Cycle IX)
$59,002
University of California, Los Angeles
Michael McNitt-Gray
Ph.D.
9RT-0065
Culture and Tobacco Among American Indian Adolescents
2006 (Cycle XV)
$827,725
University of Southern California
Jennifer Unger
Ph.D.
15RT-0111
Current legal issues in tobacco
1997 (Cycle VI)
$34,746
University of California, San Francisco
Brion Fox
S.M., J.D.
6FT-0105
Curriculum for treating nicotine dependence in psychiatry
2004 (Cycle XIII)
$269,243
University of California, San Francisco
Judith Prochaska
Ph.D., M.P.H.
13KT-0152
Cytokine gene-modified dendritic cells for lung cancer
2000 (Cycle IX)
$590,523
University of California, Los Angeles
Steven Dubinett
M.D.
9RT-0118
Defining mutagenesis pathways in tobacco-related cancer
2005 (Cycle XIV)
$58,993
Scripps Research Institute
Bryan O'Neill
BA Chemistry
14DT-0137
Deposition of inhaled carcinogens in ETS
2001 (Cycle X)
$210,446
University of California, Irvine
Michael Oldham
M.S.
10KT-0003
Depression as a predictor of smoking treatment outcome
2001 (Cycle X)
$52,467
University of California, San Francisco
G. Scott Acton
Ph.D.
10FT-0248
Detection of occult metastases in patients with lung cancer
1999 (Cycle VIII)
$723,842
University of Southern California
Richard Cote
M.D.
8RT-0061
Determinants of smoking among gay & lesbian youth
2000 (Cycle IX)
$509,771
University of California, San Francisco
Jay Paul
Ph.D.
9RT-0218
Determinants of Smoking Prevalence among Cambodian Americans
2007 (Cycle XVI)
$693,630
California State University, Long Beach Foundation
Kimthai Kuoch
16AT-1300H
Determinants of Smoking Prevalence among Cambodian Americans
2007 (Cycle XVI)
$693,630
California State University, Long Beach Foundation
Robert Friis
Ph.D.
16AT-1300H
Determinants of Susceptibility to Oxidized Lipoproteins
1995 (Cycle IV)
$495,384
University of California, Los Angeles
Alan Fogelman
M.D.
4RT-0074
Determining how cholesterol-rich Lp(a) causes heart disease
1998 (Cycle VII)
$797,092
J. David Gladstone Institutes
Robert Pitas
Ph.D.
7RT-0018
Developing new vaccines for lung cancer
1998 (Cycle VII)
$398,511
University of California, Los Angeles
Michael Roth
M.D.
7RT-0040
Developing policy to reverse cigar trend: roles of media
1997 (Cycle VI)
$249,785
University of California, San Francisco
Lisa Bero
Ph.D.
6RT-0026
Developing treatments that lower blood cholesterol levels
1997 (Cycle VI)
$746,536
Scripps Research Institute
Linda Curtiss
Ph.D.
6RT-0034
Development of a blood test for pancreatic cancer
1997 (Cycle VI)
$308,819
Stanford University
Anson Lowe
M.D.
6RT-0439
Development of a new device to measure ambulatory smoking
2000 (Cycle IX)
$72,238
University of California, Los Angeles
Richard Olmstead
Ph.D.
9IT-0035
Development of Fluorescent Probes for Sensing DNA Mismatches
2006 (Cycle XV)
$65,369
California Institute of Technology
Mi Hee Lim
Ph.D.
15FT-0166
Development of nicotine withdrawal measures
2005 (Cycle XIV)
$50,956
University of California, San Diego
Svetlana Semenova
Ph.D.
14IT-0053A
Development of nicotine withdrawal measures
2005 (Cycle XIV)
$91,173
Scripps Research Institute
Svetlana Semenova
Ph.D.
14IT-0053
Developmental Relationship between NK and T-Cell Lineages
1995 (Cycle IV)
$434,126
California Institute of Technology
Ellen Rothenberg
Ph.D.
4RT-0264
Diabetes & tobacco exposure in So CA American Indians
2005 (Cycle XIV)
$468,390
University of California, San Diego
Deborah Morton
Ph.D.
14RT-0024H
Diagnostic tools of HDL damage by tobacco smoke
2000 (Cycle IX)
$113,878
Lawrence Berkeley National Laboratory
John Bielicki
Ph.D.
9IT-0083
Diaphragm adaptations following treatment for emphysema
1997 (Cycle VI)
$469,400
Cedars-Sinai Medical Center
Michael Lewis
M.D.
6RT-0144
Dietary fat and ETS effects on lung epithelial biology
2003 (Cycle XII)
$99,827
University of California, Davis
Laura Van Winkle
Ph.D.
12IT-0191
Discovery of serum markers of lung cancer
1998 (Cycle VII)
$120,300
Cedars-Sinai Medical Center
Phillip Koeffler
M.D.
7IT-0066
Disproportionate cost of smoking for communities of color
2004 (Cycle XIII)
$278,980
University of California, San Francisco
Wendy Max
Ph.D.
13RT-0030
Dissecting signaling pathways to test cancer-killing agents
1998 (Cycle VII)
$69,694
University of California, San Diego
Yi Chen
Ph.D.
7FT-0150
Dissemination of a smoking cessation program for in patients
1999 (Cycle VIII)
$710,621
Stanford University
C. Barr Taylor
M.D.
8RT-0031
Dissemination of the Rx for Change in Psychiatry Curriculum
2008 (Cycle XVII)
$439,283
University of California, San Francisco
Judith Prochaska
Ph.D., M.P.H.
17RT-0077
Dissuading at-risk youth from smoking via mass media
2000 (Cycle IX)
$610,340
University of California, Irvine
Cornelia Pechmann
Ph.D.
9RT-0209H
DNA replication, regulation of the cell cycle, and cancer
2000 (Cycle IX)
$571,742
California Institute of Technology
Judith Campbell
Ph.D.
9RT-0179
Do receptors mediate the effects of nicotine on anxiety?
2005 (Cycle XIV)
$291,060
Salk Institute for Biological Studies
Tammy Booker
Ph.D.
14KT-0113
Does nicotine alter intercellular communication pathways?
1997 (Cycle VI)
$68,864
University of California, San Diego
Ching-Yi Chen
Ph.D.
6FT-0135
Does nicotine exposure inhibit convective drug delivery ?
2007 (Cycle XVI)
$189,400
La Jolla Bioengineering Institute
Ugur Ozerdem
M.D.
16IT-0212A
Does nicotine increase sprouting of pericyte tubes?
2004 (Cycle XIII)
$207,300
La Jolla Institute for Molecular Medicine
Ugur Ozerdem
M.D.
13IT-0067
Does nicotine inhibit anticancer activities of Vitamin A?
1997 (Cycle VI)
$788,808
The Burnham Institute for Medical Research
Xiao-Kun Zhang
Ph.D.
6RT-0168
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma
1994 (Cycle III)
$389,719
University of California, San Francisco
Rik Derynck
Ph.D.
3RT-0104
Does tobacco exposure delay conception?
2003 (Cycle XII)
$447,845
Sequoia Foundation
Michelle Pearl
Ph.D.
12RT-0202
Dynamics of state tobacco control making
1999 (Cycle VIII)
$70,000
University of California, San Francisco
Michael Givel
Ph.D.
8FT-0095
Dysregulation of VSMC signaling induced by nicotine
2001 (Cycle X)
$683,510
Stanford University
Philip Tsao
Ph.D.
10RT-0298
Early detection of oral cancer
1998 (Cycle VII)
$74,901
University of California, Irvine
Petra Wilder-Smith
D.D.S., Ph.D.
7IT-0192
Economic Analysis of Smoking Cessation Therapies
1999 (Cycle VIII)
$270,206
University of California, San Francisco
James Milton Lightwood
Ph.D.
8RT-0007
Economic Effects of California Cigarette Tax
1998 (Cycle VII)
$98,528
University of California, Berkeley
Teh-Wei Hu
Ph.D.
7ST-0201
Economic Impact of Secondhand Smoke for Communities of Color
2007 (Cycle XVI)
$216,038
University of California, San Francisco
Wendy Max
Ph.D.
16RT-0075
Effect of cigarette smoke and nicotine on taste processing
2002 (Cycle XI)
$70,000
University of California, Davis
Christopher Simons
Ph.D.
11FT-0101
Effect of cigarette smoking on pulmonary metastasis
2001 (Cycle X)
$36,236
University of California, Davis
Susan Murin
M.D.
10IT-0264
Effect of estrogen on ETS-induced glyco-oxidation
2000 (Cycle IX)
$24,692
University of California, Davis
Jeana LeAnn Benton
B.S.
9DT-0130
Effect of maternal smoking on early human development
2003 (Cycle XII)
$505,975
University of California, San Francisco
Susan Fisher
Ph.D.
12RT-0059
Effect of Maternal Smoking on Early Human Development
2006 (Cycle XV)
$489,025
University of California, San Francisco
Susan Fisher
Ph.D.
15RT-0037
Effect of maternal smoking on human placental development
1997 (Cycle VI)
$450,000
University of California, San Francisco
Susan Fisher
Ph.D.
6RT-0304
Effect of maternal smoking on human placental development
2000 (Cycle IX)
$515,124
University of California, San Francisco
Susan Fisher
Ph.D.
9RT-0112
Effect of nicotine on bone marrow cells
2001 (Cycle X)
$520,381
La Jolla Institute for Molecular Medicine
Sophia Khaldoyanidi
M.D., Ph.D.
10KT-0036H
Effect of nicotine on fetal hemopoietic stem cell migration
2002 (Cycle XI)
$152,352
La Jolla Institute for Molecular Medicine
Sophia Khaldoyanidi
M.D., Ph.D.
11IT-0020
Effect of Oxidation on Rate of ApoA-I - HDL Exchange
2007 (Cycle XVI)
$75,000
Children's Hospital Oakland Research Institute
Giorgio Cavigiolio
Ph.D.
16FT-0054
Effect of PDGF inhibition on angiogenesis in lung cancer
2005 (Cycle XIV)
$74,500
University of California, San Francisco
Beverly Falcon
Ph.D.
14FT-0152
Effect of secondhand smoke on pulmonary t cell recruitment
1999 (Cycle VIII)
$69,094
University of California, Davis
Lisa Miller
Ph.D.
8IT-0054
Effect of sidestream smoke on lung injury and repair
1997 (Cycle VI)
$214,070
University of California, Davis
Laura Van Winkle
Ph.D.
6KT-0306
Effect of Sidestream Tobacco Smoke on Parkin Null Mice
2006 (Cycle XV)
$48,256
University of California, Los Angeles
Owen Kelly
Ph.D.
15FT-0068
Effect of smoke and gender on bronchiolar injury and repair
2002 (Cycle XI)
$413,288
University of California, Davis
Laura Van Winkle
Ph.D.
11RT-0258
Effect of smoke and gender on bronchiolar injury and repair
2005 (Cycle XIV)
$418,207
University of California, Davis
Laura Van Winkle
Ph.D.
14RT-0132
Effect of Smoking on Success Rate of In Vitro Fertilization
1995 (Cycle IV)
$449,805
University of California, San Diego
Hillary Klonoff-Cohen
Ph.D.
4RT-0032
Effect of Tobacco on Rat Lung Alveolar Lining Liquid
1995 (Cycle IV)
$643,213
Lawrence Berkeley National Laboratory
Jacob Bastacky
M.D.
4RT-0382
Effect of tobacco related policy change on smoking behavior
1999 (Cycle VIII)
$261,672
University of California, San Diego
David Burns
M.D.
8RT-0094
Effect of tobacco smoke on leucocyte adhesion in vivo
2001 (Cycle X)
$1,023,946
La Jolla Institute for Molecular Medicine
Pragada Sriramarao
Ph.D.
10RT-0171
Effect of tobacco smoke on leukocyte adhesion in vivo
1998 (Cycle VII)
$754,361
La Jolla Institute for Molecular Medicine
Pragada Sriramarao
Ph.D.
7RT-0197
Effect of tobacco smoke on lung airway surface liquid
1998 (Cycle VII)
$115,658
Children's Hospital Oakland Research Institute
Jacob Bastacky
M.D.
7RT-0133A
Effect of tobacco smoke on nitric oxide synthesis
1999 (Cycle VIII)
$70,000
University of California, Davis
Patrick Wong
Ph.D.
8FT-0150
Effect of tobacco toxins on human germ cell development
2006 (Cycle XV)
$33,290
University of California, San Francisco
Kehkooi Kee
Ph.D.
15FT-0178
Effect of tobacco toxins on human germ cell development
2006 (Cycle XV)
$41,710
Stanford University
Kehkooi Kee
Ph.D.
15FT-0178A
Effect of tobacco-related policy change on smoking behavior
2002 (Cycle XI)
$303,504
University of California, San Diego
David Burns
M.D.
11RT-0245
Effective diffusion of evidence-based tobacco curricula
2002 (Cycle XI)
$47,747
University of Southern California
Silvana Skara
MPH
11DT-0137
Effectiveness Evaluation of the I Decide Program
2006 (Cycle XV)
$162,304
University of Southern California
Louise Rohrbach
Ph.D., M.P.H.
15HT-1600
Effectiveness of a large prenatal tobacco reduction program
2004 (Cycle XIII)
$425,181
Sequoia Foundation
Michelle Pearl
Ph.D.
13RT-0070
Effectiveness of two different regimens in smoking clinic
1999 (Cycle VIII)
$272,989
University of California, Los Angeles
Scott Eliot Sherman
M.D., M.P.H.
8RT-0068
Effects of Disturbed Flow on Endothelial Cell Function
1995 (Cycle IV)
$52,345
University of California, Los Angeles
Henry Honda
M.D.
4FT-0358
Effects of Environmental Tobacco Smoke on Pulmonary Allergy
1995 (Cycle IV)
$256,805
University of California, Davis
Laurel Gershwin
D.V.M., Ph.D.
4RT-0299
Effects of environmental tobacco smoke on pulmonary allergy
1998 (Cycle VII)
$282,568
University of California, Davis
Laurel Gershwin
D.V.M., Ph.D.
7RT-0107
Effects of environmental tobacco smoke on the artery wall
1998 (Cycle VII)
$449,673
University of California, Davis
John Rutledge
M.D.
7RT-0070
Effects of exposure to secondhand smoke
1999 (Cycle VIII)
$194,404
Kaiser Foundation Research Institute
Carlos Iribarren
M.D., Ph.D., M.P.H.
8KT-0028
Effects of Legislation on ETS Exposure in California
1997 (Cycle VI)
$245,189
University of California, San Diego
Arthur Farkas
Ph.D.
6PT-5002
Effects of nicotine exposure in utero on brain cell death
1997 (Cycle VI)
$74,499
University of California, San Diego
Jerold Chun
M.D., Ph.D.
6IT-0239
Effects of Nicotine on Brain Development
1999 (Cycle VIII)
$55,404
Cedars-Sinai Medical Center
Christine Cloak
8DT-0170
Effects of nicotine on fetal hematopoiesis
2007 (Cycle XVI)
$764,400
Torrey Pines Institute for Molecular Studies
Sophia Khaldoyanidi
M.D., Ph.D.
16RT-0134
Effects of nicotine on hematopoietic stem cell migration
2005 (Cycle XIV)
$74,500
La Jolla Institute for Molecular Medicine
Naira Serobyan
M.D.
14FT-0126
Effects of nicotine on postinfarction cardiac remodeling
1998 (Cycle VII)
$459,799
University of California, San Diego
Francisco Villarreal
M.D., Ph.D.
7RT-0109H
Effects of nicotine on schizophrenia-like cognitive deficits
2006 (Cycle XV)
$60,000
University of California, San Diego
Nurith Amitai
B.S.
15DT-0048
Effects of nicotine on taste processing
2001 (Cycle X)
$24,834
University of California, Davis
Christopher Simons
Ph.D.
10DT-0197
Effects of nicotine withdrawal on aviator performance
2001 (Cycle X)
$515,243
Stanford University
Jerome Yesavage
M.D.
10RT-0186
Effects of Outlet/Ad Density on Teen Smking and Brand Choice
2005 (Cycle XIV)
$410,979
Stanford University
Lisa Henriksen
Ph.D.
14RT-0103
Effects of passive smoking and pregnancy
1999 (Cycle VIII)
$565,186
Lawrence Livermore National Laboratory
Kenneth Turteltaub
Ph.D.
8RT-0072
Effects of perinatal nicotine on the Brain
1997 (Cycle VI)
$93,122
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Russell Poland
Ph.D.
6IT-0071
Effects of prenatal nicotine exposure on nicotinic receptors
2000 (Cycle IX)
$471,654
University of California, San Francisco
Peter Sargent
Ph.D.
9RT-0101
Effects of pro and anti-smoking cues in stores on craving
2004 (Cycle XIII)
$373,894
Stanford University
Lisa Henriksen
Ph.D.
13RT-0123
Effects of PSA content and formal features on smoking norms
1999 (Cycle VIII)
$44,284
Stanford University
Michael Antecol
Ph.D.
8FT-0149
Effects of Selegiline on craving for nicotine
1998 (Cycle VII)
$100,450
Stanford University
Joel Killen
Ph.D.
7RT-0094
Effects of side stream tobacco smoke on DNA deletions
2005 (Cycle XIV)
$58,876
University of California, Los Angeles
Mitsuko Yamamoto
B.S.
14DT-0121
Effects of social capital on smoking: elasticity & pathways
2005 (Cycle XIV)
$98,854
University of California, Berkeley
Richard Scheffler
Ph.D.
14IT-0175
Effects of tobacco on inflammatory cell responses
1997 (Cycle VI)
$223,585
University of California, Davis
Lisa Miller
Ph.D.
6KT-0411
Effects of tobacco smoke exposure on hormones and fertility
1998 (Cycle VII)
$115,335
Sequoia Foundation
Gayle Windham
Ph.D.
7RT-0119
Effects of tobacco smoke on airway bactericidal activity
2001 (Cycle X)
$87,079
University of California, Davis
Yuan-Pu Di
Ph.D.
10KT-0261
Effects of Tobacco Smoke on Mucin Production in Rat Airways
1995 (Cycle IV)
$356,400
University of California, San Francisco
Carol Basbaum
Ph.D.
4RT-0210
Effects of Tobacco Taxation Upon Population Health Status
1997 (Cycle VI)
$206,547
University of California, San Diego
Robert Kaplan
Ph.D.
6PT-2004
Effects of tobacco-induced gamete damage on embryogenesis
2004 (Cycle XIII)
$158,853
Lawrence Livermore National Laboratory
Francesco Marchetti
Ph.D.
13RT-0140
Effects of tobacco-induced gamete damage on embryogenesis
2004 (Cycle XIII)
$608,740
Lawrence Berkeley National Laboratory
Francesco Marchetti
Ph.D.
13RT-0140A
Efficacy of the nicotine patch in adolescents & young adults
2002 (Cycle XI)
$69,800
University of California, San Francisco
Mark Rubinstein
M.D.
11FT-0233
Electrophysiological Effects of Perinatal Nicotine Exposure
1995 (Cycle IV)
$446,225
Scripps Research Institute
Cindy Ehlers
Ph.D.
4RT-0285
Electrophysiological Effects of Perinatal Nicotine Exposure
1995 (Cycle IV)
$293,752
San Diego State University Research Foundation
Edward Riley
Ph.D.
4RT-0285S
Emotional intelligence and smoking across ethnicity
2000 (Cycle IX)
$52,392
University of Southern California
Dennis Trinidad
Ph.D., M.P.H.
9DT-0174
Engineering Salmonella for lung cancer therapy
2007 (Cycle XVI)
$291,600
Sidney Kimmel Cancer Center
Nabil Arrach
Ph.D.
16KT-0045
Environmental contexts of smoking for Southeast Asians
2004 (Cycle XIII)
$728,324
Pacific Institute for Research and Evaluation
Juliet Lee
BA, MA, PhD
13RT-0058H
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$204,722
Asian Pacific Partners for Empowerment Advocacy & Leadership
Rod Lew
MPH
13AT-3000A
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$311,543
Assoc of Asian Pacific Community Health Organizations
Rod Lew
MPH
13AT-3000
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$149,610
CSU Fullerton Auxiliary Services Corporation
Sora Park Tanjasiri
DrPH, MPH
13AT-3001
Environmental tobacco smoke and early atherosclerosis
1997 (Cycle VI)
$383,814
University of Southern California
Wendy Mack
Ph.D.
6RT-0137
Environmental tobacco smoke and newborn lung development
1997 (Cycle VI)
$440,500
University of California, Davis
Kent Pinkerton
Ph.D.
6RT-0327
Environmental tobacco smoke effects on lung surfactant
1999 (Cycle VIII)
$423,216
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
8RT-0077
Environmental tobacco smoke effects on lung surfactant
2002 (Cycle XI)
$406,444
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
11RT-0222
Environmental tobacco smoke effects on lung surfactant
1999 (Cycle VIII)
$47,656
University of California, Santa Barbara
Junqi Ding
8DT-0171
Environmental tobacco smoke exposure & adult asthma
2001 (Cycle X)
$460,032
University of California, San Francisco
Mark Eisner
M.D., M.P.H.
10RT-0108
Enzymatic targets for anticancer therapy
2002 (Cycle XI)
$267,304
J. David Gladstone Institutes
Martin Bergo
M.D., Ph.D.
11KT-0087
Epigenetic Regulation of Airway MUC gene expression by smoke
2007 (Cycle XVI)
$420,000
University of California, Davis
Reen Wu
Ph.D.
16RT-0127
Ethnic and gender variation in nicotine detoxification
2003 (Cycle XII)
$424,142
SRI International
Huijun Ring
Ph.D.
12KT-0234
Ethnic difference in cigarette smoking dynamics among youth
1999 (Cycle VIII)
$366,852
University of Southern California
Xinguang Chen
Ph.D.
8RT-0034
Ethnicity and school-level effect on CA student tobacco use
2004 (Cycle XIII)
$422,120
University of California, Los Angeles
William McCarthy
Ph.D.
13RT-0051H
ETS Effects on airway development in the primate lung
1998 (Cycle VII)
$483,652
University of California, Davis
Kent Pinkerton
Ph.D.
7RT-0118
ETS effects on breathing patterns
2000 (Cycle IX)
$590,780
University of California, Davis
Jesse Joad
M.D.
9RT-0010
ETS Effects on Lung Surfactant
2005 (Cycle XIV)
$419,000
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
14RT-0077
ETS effects on pulmonary breathing patterns
1997 (Cycle VI)
$446,954
University of California, Davis
Jesse Joad
M.D.
6RT-0024
ETS exposures in the California Teachers Study cohort
1998 (Cycle VII)
$449,677
Public Health Institute
Peggy Reynolds
Ph.D.
7RT-0142
Evaluating Mechanisms of Change in a Smoking Intervention
2008 (Cycle XVII)
$202,500
RAND Corporation
Harold Green
Ph.D.
17IT-0007
Evaluation of ad strategies for preventing youth tobacco use
1997 (Cycle VI)
$136,953
University of California, Irvine
Cornelia Pechmann
Ph.D.
6RT-0038
Evaluation of office ETS exposure in relation to AB 13
1999 (Cycle VIII)
$242,063
Public Health Institute
Leon Alevantis
M.S.
8RT-0157
Evaluation of office ETS exposure in relation to AB13
1999 (Cycle VIII)
$208,554
Lawrence Berkeley National Laboratory
William Fisk
B.S., M.S.
8RT-0157S
Experimental evaluation of minors' access to tobacco
2000 (Cycle IX)
$655,347
San Diego State University Research Foundation
Hope Landrine
Ph.D.
9RT-0043
Explaining racial differences in smoking
1999 (Cycle VIII)
$151,430
San Diego State University Research Foundation
Hope Landrine
Ph.D.
8RT-0013A
Explaining racial differences in smoking
1999 (Cycle VIII)
$149,280
Public Health Foundation Enterprises, Inc.
Hope Landrine
Ph.D.
8RT-0013
Exploration of tobacco use in Asian Pacific Islander youth
2002 (Cycle XI)
$92,076
Assoc of Asian Pacific Community Health Organizations
Sora Park Tanjasiri
DrPH, MPH
11BT-1600
Exploration of tobacco use in Asian Pacific Islander youth
2002 (Cycle XI)
$92,076
Assoc of Asian Pacific Community Health Organizations
Rod Lew
MPH
11BT-1600
Exploring tobacco cessation services on CA college campuses
2001 (Cycle X)
$81,995
Public Health Institute
Dianne Barker
M.H.S.
10IT-0265
Exploring transdisciplinary scientific collaboration
2001 (Cycle X)
$29,040
University of California, Irvine
Juliana Lynn Fuqua
Ph.D.
10DT-0178
Expos children to secondhand smoke through cntaminated homes
2004 (Cycle XIII)
$754,504
San Diego State University Research Foundation
Georg Matt
Ph.D.
13RT-0161H
Exposure to Secondhand Smoke: Effects of Proximity
2007 (Cycle XVI)
$672,582
Stanford University
Lynn Hildemann
Ph.D.
16RT-0150
Expressing & Cloning of ATP-Sensitive Potassium Channels
1995 (Cycle IV)
$286,163
University of California, Santa Barbara
Carol Vandenberg
Ph.D.
4RT-0289
Expression of the Human apo-B Gene in Transgenic Mice
1995 (Cycle IV)
$211,090
J. David Gladstone Institutes
Beatriz Levy-Wilson
Ph.D.
4RT-0308
Expression of the Human apo-B Gene in Transgenic Mice
1995 (Cycle IV)
$569,759
Palo Alto Medical Foundation Research Institute
Beatriz Levy-Wilson
Ph.D.
4RT-0308A
Family factors in smoking acquisition among Latino youth
1998 (Cycle VII)
$865,636
San Diego State University Research Foundation
Rafael Laniado-Laborin
M.D., MPH
7RT-0049
Fertility smoking and early mammalian development
2004 (Cycle XIII)
$392,451
University of California, Riverside
Prudence Talbot
Ph.D.
13RT-0068
Fertility, smoking and early mammalian development
1997 (Cycle VI)
$452,243
University of California, Riverside
Prudence Talbot
Ph.D.
6RT-0039
Fertility, smoking and early mammalian development
2001 (Cycle X)
$454,490
University of California, Riverside
Prudence Talbot
Ph.D.
10RT-0239
Fertility, Smoking, and Early Mammalian Development
1995 (Cycle IV)
$321,193
University of California, Riverside
Prudence Talbot
Ph.D.
4RT-0081
Focal adhesion kinase regulation of Cox-2 in lung cancer
2003 (Cycle XII)
$74,520
Scripps Research Institute
Satyajit Mitra
Ph.D.
12FT-0122
Function and Regulation of the Retinoblastoma Protein
1995 (Cycle IV)
$385,031
University of California, San Diego
James Feramisco
Ph.D.
4RT-0251
Functional Antagonists of Nicotine
1995 (Cycle IV)
$236,936
Northern California Institute for Research & Education
S. Paul Berger
M.D.
4KT-0313
Functional MRI of neural activation
1997 (Cycle VI)
$48,447
University of California, Los Angeles
Shantanu Sinha
Ph.D.
6IT-0255
Functional significance of the protein CD40 in lung cancer
1998 (Cycle VII)
$35,000
University of California, San Diego
Kenneth Grudko
M.D.
7FT-0047
Functions of IRF-1 and Smad3 interaction in lung cancer
2001 (Cycle X)
$69,750
University of California, San Francisco
Pierre Lee
Ph.D.
10FT-0141
Fusion proteins that convert VEGF into a cell death factor
2007 (Cycle XVI)
$100,000
University of California, San Francisco
Timothy Quinn
M.D.
16IT-0009
Gastroschisis: maternal smoking and genetic variation
2007 (Cycle XVI)
$673,269
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
16RT-0086
Gene Augmentation Therapy for Tobacco Induced Emphysema
1995 (Cycle IV)
$224,786
University of California, Davis
Robert Malone
M.D.
4KT-0205
Gene Markers for Hypertension
1995 (Cycle IV)
$356,151
University of California, San Francisco
Theodore Kurtz
M.D.
4RT-0362
Gene therapy for emphysema
1997 (Cycle VI)
$443,179
University of California, San Francisco
Francis Szoka
Ph.D.
6RT-0109
Genes affecting nicotine response in C. elegans
2006 (Cycle XV)
$100,000
University of California, San Diego
William Schafer
Ph.D.
15RT-0216
Genetic links to nicotine addiction: ethics of testing teens
1999 (Cycle VIII)
$115,591
Stanford University
Thomas Raffin
M.D.
8IT-0123
Genetic Susceptibility to Lung Cancer
1995 (Cycle IV)
$104,580
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Henry Lin
M.D.
4IT-0130
Genetic susceptibility to tobacco-induced lung cancer
1998 (Cycle VII)
$406,120
University of California, Los Angeles
Oliver Hankinson
Ph.D.
7RT-0061
Genetics and Impulsivity in Smoking Initiation
2008 (Cycle XVII)
$283,612
Veterans Medical Research Foundation
Neal Doran
Ph.D.
17KT-0027
Genomic Assay to Identify Targets of Anticancer Therapeutics
2008 (Cycle XVII)
$75,000
Stanford University
Nolan Ko
Ph.D.
17FT-0056
Genomics & transcriptome of oral precncr prgrssion in smkers
2004 (Cycle XIII)
$189,541
University of California, Los Angeles
Xiaofeng Zhou
Ph.D.
13KT-0028
Geography of underage tobacco retail sales in Los Angeles
2003 (Cycle XII)
$622,260
Pacific Institute for Research and Evaluation
Robert Lipton
BA, MA, MPH, Ph.D.
12RT-0093
Global determinants of tobacco use onset in diverse youth
1998 (Cycle VII)
$280,749
Education Training and Research Associates, Inc.
Scott Carvajal
Ph.D., MPH
7KT-0151H
Grainyhead-Like Transcription factor in Airway Epithelium
2008 (Cycle XVII)
$60,000
University of California, Irvine
Ambica Bhandari
Masters in Biotechnology
17DT-0192
Heat shock proteins as biomarkers of lung oxidant stress
2000 (Cycle IX)
$24,338
University of California, Davis
Kurt Williams
D.V.M.
9DT-0204
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke
1995 (Cycle IV)
$454,365
Lawrence Berkeley National Laboratory
Rolf Mehlhorn
Ph.D.
4RT-0240
Heparan sulfate small molecules for contro tumor cell growth
2005 (Cycle XIV)
$626,807
California Institute of Technology
Linda Hsieh-Wilson
Ph.D.
14RT-0034
-Heterologous Expression of Brain Nicotinic Acetylcholine Re
1995 (Cycle IV)
$598,774
California Institute of Technology
Henry Lester
Ph.D.
4RT-0286
High Resolution OCT for Early Airway Cancer Detection
2007 (Cycle XVI)
$480,636
University of California, Irvine
Matthew Brenner
M.D.
16RT-0082
Hmong cultural practices and patterns of tobacco use
1999 (Cycle VIII)
$83,383
California Health Collaborative
Vickie Krenz
Ph.D., M.S.P.H.
8IT-0079
Hmong smoking prevalence & tobacco uses
2001 (Cycle X)
$539,350
California State University, Fresno Foundation
Vickie Krenz
Ph.D., M.S.P.H.
10AT-1101
Hmong smoking prevalence & tobacco uses
2001 (Cycle X)
$539,350
California State University, Fresno Foundation
Pao Fang
10AT-1101
Hormone replacement therapy, smoking & lipoprotein oxidation
1998 (Cycle VII)
$385,808
Scripps Research Institute
Carole Banka
Ph.D.
7RT-0101
Hormone replacement therapy, smoking & lipoprotein oxidation
1998 (Cycle VII)
$245,584
La Jolla Institute for Molecular Medicine
Carole Banka
Ph.D.
7RT-0101A
Hormones and Tobacco: Joint Effects on Reproduction
1994 (Cycle III)
$263,611
Public Health Institute
Shanna Swan
Ph.D.
3RT-0093
How are beneficial cholesterol transport proteins produced?
1998 (Cycle VII)
$37,069
J. David Gladstone Institutes
Martin Hersberger
Ph.D.
7FT-0005
How do nic and cig smoke affect neural control of breathing?
2004 (Cycle XIII)
$392,620
University of California, Los Angeles
Xuesi Shao
M.D.
13RT-0164
How do tobacco smoke compounds impair lung surfactant?
1997 (Cycle VI)
$74,961
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
6IT-0140
How does cardiac fuel metabolism influence heart disease?
1998 (Cycle VII)
$262,005
J. David Gladstone Institutes
Murielle Marie Veniant
Ph.D.
7KT-0020
How does cigarette smoke induce cancer?
1997 (Cycle VI)
$811,518
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
6RT-0361
How does smoke activate mucin transcription in lung cells?
1998 (Cycle VII)
$432,415
University of California, San Francisco
Carol Basbaum
Ph.D.
7RT-0152
How omega-3 fatty acids prevent or slow cancer
2006 (Cycle XV)
$74,808
The Burnham Institute for Medical Research
Hu Zhou
Ph.D.
15FT-0243
How smoke induces lung damage via oxidative stress
2006 (Cycle XV)
$75,000
University of California, Davis
Michal Levy
Ph.D.
15FT-0041
Human neurophysiology of nicotine analgesia: sex differences
2000 (Cycle IX)
$595,994
University of California, San Francisco
David Becker
Ph.D.
9RT-0142
Human oocyte development and PAH exposure
2005 (Cycle XIV)
$260,944
University of California, San Francisco
Renee Reijo Pera
Ph.D.
14RT-0159
Human oocyte development and PAH exposure
2005 (Cycle XIV)
$158,556
Stanford University
Renee Reijo Pera
Ph.D.
14RT-0159A
Human tryptase gene expression: role in COPD
2000 (Cycle IX)
$545,409
University of California, San Francisco
George Caughey
M.D.
9RT-0152H
Hyperactive nicotine receptors
1997 (Cycle VI)
$486,158
California Institute of Technology
Henry Lester
Ph.D.
6RT-0044
Hyperactive nicotine receptors
2000 (Cycle IX)
$1,138,225
California Institute of Technology
Henry Lester
Ph.D.
9RT-0182
Hyperactive nicotine receptors
2003 (Cycle XII)
$675,487
California Institute of Technology
Henry Lester
Ph.D.
12RT-0245
Hypnosis for Smoking Relapse Prevention
2007 (Cycle XVI)
$509,353
University of California, San Francisco
Timothy Carmody
Ph.D.
16RT-0074
IAP Antagonists for lung cancer treatment
2004 (Cycle XIII)
$727,658
The Burnham Institute for Medical Research
John Reed
M.D., Ph.D.
13RT-0130
Identification on Tumors of Molecular Targets for NK Cells
1995 (Cycle IV)
$314,006
University of California, San Francisco
William Seaman
M.D.
4RT-0184
IL-12 genetic immunotherapy for lung cancer
1999 (Cycle VIII)
$75,000
University of California, Los Angeles
Steven Dubinett
M.D.
8IT-0035
Immune Targeted Therapy for Lung Cancer
2006 (Cycle XV)
$419,500
University of California, Los Angeles
Sherven Sharma
Ph.D.
15RT-0207
Immunopharmacotherapy as a treatment for nicotine addiction
2002 (Cycle XI)
$515,270
Scripps Research Institute
Kim Janda
Ph.D.
11RT-0174
Impact of Cultural Competence on Treatment Outcomes
2002 (Cycle XI)
$1,500
University of California, Davis
Nolan Zane
Ph.D.
11ST-0259
Impact of MPO in Tobacco-related Cardiovascular Disease
2007 (Cycle XVI)
$818,160
Sidney Kimmel Cancer Center
Wanda Reynolds
Ph.D.
16RT-0184
Impact of nicotinic signaling on neuronal gene expression
2000 (Cycle IX)
$30,055
University of California, San Diego
Karen Chang
B.A.
9DT-0147
Impact of Positive Mood on Self-Control Depletion in Smoking
2007 (Cycle XVI)
$75,000
University of California, San Francisco
Dikla Shmueli
Ph.D.
16FT-0050
Implementation of California AB 13: smoking ban in bars
1998 (Cycle VII)
$315,181
University of California, San Francisco
Lisa Bero
Ph.D.
7RT-0180
Implementation of tobacco prevention programming and smoking
2003 (Cycle XII)
$58,557
University of Southern California
Pamela Elfenbaum
MPH
12DT-0152
Implementation of tobacco programs in Calif schools
2000 (Cycle IX)
$765,192
University of Southern California
Louise Rohrbach
Ph.D., M.P.H.
9RT-0107
Importance of Rce1 and Ras in tobacco-induced cancers
1999 (Cycle VIII)
$75,209
J. David Gladstone Institutes
Martin Bergo
M.D., Ph.D.
8FT-0137
Improved chemoradiotherapy of lung cancer
2005 (Cycle XIV)
$661,920
California Pacific Medical Center Research Institute
Li-Xi Yang
M.D., Ph.D.
14RT-0177
Improved therapy of lung cancer
2000 (Cycle IX)
$668,814
California Pacific Medical Center Research Institute
Li-Xi Yang
M.D., Ph.D.
9RT-0172
Improving tobacco use assessment among youth via telephone
1997 (Cycle VI)
$347,440
University of California, Berkeley
Joel Moskowitz
Ph.D.
6RT-0371
Individual and gender differences in nicotine sensitivity
2003 (Cycle XII)
$69,495
University of California, Irvine
Minjung Park
Ph.D.
12FT-0247
Indoor measurements of environmental tobacco smoke
1997 (Cycle VI)
$634,217
Lawrence Berkeley National Laboratory
Richard Sextro
Ph.D.
6RT-0307
Inflammation, innate immunity, TLRs, and atherosclerosis
2002 (Cycle XI)
$697,650
Scripps Research Institute
Peter Tobias
Ph.D.
11RT-0073
Inflammatory compounds:role in tobacco-related lung disease
1998 (Cycle VII)
$447,367
University of California, San Diego
Timothy Bigby
M.D.
7RT-0097
Influences that promote ethnic disparities in smoking
2003 (Cycle XII)
$269,971
University of California, San Diego
Dennis Trinidad
Ph.D., M.P.H.
12KT-0158
Inheritance and Smoking in Urinary Tract & Pancreas Cancer
1995 (Cycle IV)
$248,283
University of Southern California
Thomas Mack
M.D., M.P.H.
4RT-0324
Inhibition of cell death in head and neck cancer cells
2005 (Cycle XIV)
$24,148
University of Southern California
Ram Kumar Subramanyan
M.D.
14DT-0125
Inhibition of MYC-activated gene expression by polyamides
2007 (Cycle XVI)
$75,000
California Institute of Technology
Daniel Harki
Ph.D.
16FT-0055
Innovation to prevent post-partum relapse
2000 (Cycle IX)
$75,000
University of California, San Francisco
Jennifer Haas
M.D.
9IT-0192
Instant SHS Feedback as a Catalyst for Smoke-Free Homes
2008 (Cycle XVII)
$129,917
San Diego State University Research Foundation
Neil Klepeis
17IT-0008
Integrin Cytoplasmic Domains and Ligand Affinity Modulation
1994 (Cycle III)
$522,649
Scripps Research Institute
Timothy O'Toole
Ph.D.
3RT-0320
Integrin receptors and heart disease
2005 (Cycle XIV)
$35,323
University of California, San Diego
Anthony Partridge
Ph.D.
14FT-0033
Integrins and drug resistance in small cell lung cancer
2003 (Cycle XII)
$780,144
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
12RT-0143
Interaction of LDL receptor family members with ligands
2008 (Cycle XVII)
$291,600
Children's Hospital Oakland Research Institute
Taichi Yamamoto
Ph.D.
17KT-0026
Interactions of Moesin during platelet activation
1995 (Cycle IV)
$428,524
Stanford University
Heinz Furthmayr
M.D.
4RT-0316
Interdependence - smoking behavior & mood in natural setting
1997 (Cycle VI)
$222,843
University of California, Los Angeles
Richard Olmstead
Ph.D.
6KT-0322
Internet health research center: smoking, Latinos, & the Web
2004 (Cycle XIII)
$535,096
University of California, San Francisco
Ricardo Munoz
Ph.D.
13RT-0050H
Internet-enhanced proactive telephone counseling
2002 (Cycle XI)
$674,731
Veterans Medical Research Foundation
Leslie Lenert
M.D., M.S.
11RT-0096
Investigating College Student Cigarette Smoking Self-change
2007 (Cycle XVI)
$138,596
Veterans Medical Research Foundation
Mark Myers
Ph.D.
16IT-0208
Involvement of PI3K pathway in bladder cancer invasion
2002 (Cycle XI)
$224,984
University of California, Davis
Colleen Sweeney
Ph.D.
11KT-0236
IRAK-1 & active TGF-beta: Counter-regulators in emphysema?
2003 (Cycle XII)
$69,000
University of California, San Francisco
George Su
M.D.
12FT-0123
Irritant & Analgesic Effects of Nicotine
1995 (Cycle IV)
$75,000
University of California, Davis
Earl Carstens
Ph.D.
4IT-0087
Irritant and analgesic effects of nicotine
2002 (Cycle XI)
$226,650
University of California, Davis
Earl Carstens
Ph.D.
11RT-0053
Irritant and pain-reducing effects of nicotine
1997 (Cycle VI)
$415,704
University of California, Davis
Earl Carstens
Ph.D.
6RT-0231
Isolation of a Tumor Promoter Induced C-Fos Kinase
1995 (Cycle IV)
$55,000
University of California, San Diego
Tuula Kallunki
Ph.D.
4FT-0105
Isolation of lung tumor proteins for a novel treatment
1998 (Cycle VII)
$75,000
University of California, San Diego
Michael Kelner
M.D., M.S.
7IT-0001
Isothiocyantes among African Americans and Caucasions
2002 (Cycle XI)
$73,270
University of California, Irvine
Catherine Carpenter
M.P.H., Ph.D.
11IT-0082
Keep me smokefree
1998 (Cycle VII)
$550,002
Education Training and Research Associates, Inc.
Carol D'Onofrio
DrPH
7RT-0090
Latino and Asian American college students' smoking
2003 (Cycle XII)
$59,500
University of California, Riverside
Michiko Otsuki
Ph.D.
12DT-0157
LDL pathophysiology and lipoprotein structure
2003 (Cycle XII)
$527,245
Children's Hospital Oakland Research Institute
Robert Ryan
Ph.D.
12RT-0014
Lesbian, gay, bisexual and transgender tobacco use
2004 (Cycle XIII)
$302,119
Kaiser Foundation Research Institute
Elisabeth Gruskin
DrPH
13RT-0084
Life histories: Chinese-American elders' smoking encounters
2000 (Cycle IX)
$17,146
Stanford University
Matthew Kohrman
Ph.D.
9IT-0066
Lifetime passive smoke exposure and breast cancer in the CTS
2004 (Cycle XIII)
$285,300
Northern California Cancer Center
Peggy Reynolds
Ph.D.
13RT-0018A
Lifetime passive smoke exposure and breast cancer in the CTS
2004 (Cycle XIII)
$122,659
Public Health Institute
Peggy Reynolds
Ph.D.
13RT-0018
Lipoprotein classes and susceptibility to atherosclerosis
1998 (Cycle VII)
$702,940
J. David Gladstone Institutes
Stephen Young
M.D.
7RT-0032
Liposome targeted chemotherapy to treat lung cancer
1999 (Cycle VIII)
$75,000
University of California, San Francisco
Francis Szoka
Ph.D.
8IT-0138
Long-term adherence after pulmonary rehabilitation for COPD
2001 (Cycle X)
$56,118
University of California, San Diego
Pia Santiago
B.A.
10DT-0212
Low-Cost Contingency Management for Smoking Cessation
2008 (Cycle XVII)
$478,751
University of California, San Francisco
Timothy Carmody
Ph.D.
17RT-0081
Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth
1998 (Cycle VII)
$1,955,276
University of Southern California
C. Anderson Johnson
Ph.D.
7PT-7002
Lung cancer therapy with in vivo-generated dendritic cells
2001 (Cycle X)
$225,000
University of California, Los Angeles
Saroj Basak
10KT-0086
Lung cancer treatment: The total synthesis of ineleganolide
2005 (Cycle XIV)
$59,700
California Institute of Technology
Jennifer Roizen
B.A.
14DT-0004
Lung volume reduction surgery in an animal emphysema model
2000 (Cycle IX)
$456,336
University of California, Irvine
Matthew Brenner
M.D.
9RT-0094
Lung volume reduction surgery in an emphysema model
1997 (Cycle VI)
$404,139
University of California, Irvine
Matthew Brenner
M.D.
6RT-0158
Macrophage DAP12 pathway in emphysema
2007 (Cycle XVI)
$387,237
University of California, San Francisco
Laura Koth
M.D.
16RT-0072
Macrophage function in atherosclerosis
2000 (Cycle IX)
$709,200
Scripps Research Institute
Linda Curtiss
Ph.D.
9RT-0161
Macular pigment regeneration upon smoking cessation
1997 (Cycle VI)
$74,988
University of California, Berkeley
Theodore Cohn
Ph.D.
6IT-0324
Major Local Tobacco Control Ordinances in the United States
1997 (Cycle VI)
$26,244
American Nonsmokers' Rights Foundation
Robin Hobart
M.P.P., M.P.H.
6ST-0454
Mapping of Genetic Loci for Nicotine Dependence
1998 (Cycle VII)
$982,095
Ernest Gallo Clinic and Research Center
Kirk Wilhelmsen
M.D., Ph.D.
7PT-2003
Marketing low-tar cigarettes and new harm-reduced products
2005 (Cycle XIV)
$74,500
University of California, San Francisco
Stacey Anderson
Ph.D.
14FT-0013
Maternal DNA repair of tobacco-induced sperm lesions
1998 (Cycle VII)
$1,046,880
Lawrence Livermore National Laboratory
Andrew Wyrobek
Ph.D.
7RT-0073
Maternal Smoking Habit Modification Via Fetal Visualization
1995 (Cycle IV)
$54,471
University of California, San Diego
Dolores Pretorius
M.D.
4IT-0218A
MCP-1 and TGFb in pulmonary emphysema
2002 (Cycle XI)
$78,241
University of California, San Francisco
David Morris
M.D.
11KT-0223
Measuring adolescent smoking cessation motives and methods
2001 (Cycle X)
$103,273
Veterans Medical Research Foundation
Mark Myers
Ph.D.
10IT-0280
Measuring prenatal tobacco exposure in newborn blood spots
2008 (Cycle XVII)
$506,927
Sequoia Foundation
Juan Yang
Ph.D.
17RT-0138
Mechanism of apparent long-term nicotinic inactivation
2000 (Cycle IX)
$20,565
University of California, Riverside
Li Jia
M.S.
9DT-0156
Mechanism of DNA break repair in germline cells
2007 (Cycle XVI)
$75,000
University of California, Davis
Amitabh Nimonkar
Ph.D.
16FT-0069
Mechanism of nicotine action in developing lung
2000 (Cycle IX)
$720,281
University of Southern California
Carol Wuenschell
Ph.D.
9RT-0238
Mechanism of smoke-induced MUC5B gene expression
2001 (Cycle X)
$392,117
University of California, Davis
Reen Wu
Ph.D.
10RT-0262
Mechanism of stress effects on weight in nicotine withdrawal
1998 (Cycle VII)
$407,019
University of California, San Francisco
Jon Levine
M.D., Ph.D.
7RT-0068
Mechanism of TGF-a shedding in lung cancer development
2003 (Cycle XII)
$69,600
University of California, San Francisco
Yang Xiao
Ph.D.
12FT-0179
Mechanisms by which tobacco accelerates atherosclerosis
1998 (Cycle VII)
$675,731
Stanford University
John Cooke
M.D., Ph.D.
7RT-0128
Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco
1994 (Cycle III)
$314,974
Stanford University
Gary Gibbons
M.D.
3KT-0375
Mechanisms of targeted therapy resistance in lung cancer
2006 (Cycle XV)
$358,500
University of California, Los Angeles
Kostyantyn Krysan
Ph.D.
15RT-0152
Mechanisms of Tobacco-Induced Retinal Neovascularization
2006 (Cycle XV)
$155,550
Stanford University
John Cooke
M.D., Ph.D.
15IT-0257
Mechanisms of Tumor Suppressor in Lung Cancer Initiation
2008 (Cycle XVII)
$75,000
University of California, Davis
Jie Liu
Ph.D.
17FT-0046
Mechanisms underlying diaphragm adaptations in emphysema
1998 (Cycle VII)
$642,624
Cedars-Sinai Medical Center
Mario Fournier
Ph.D.
7RT-0161
Mechanisms underlying modulations of respiration by nicotine
2001 (Cycle X)
$330,458
University of California, Los Angeles
Xuesi Shao
M.D.
10RT-0241
Media and smoking among adolescent girls across ethnicity
1999 (Cycle VIII)
$53,987
University of Southern California
Dongyun Yang
M.D.
8DT-0175
Membrane proteins and TGF-alpha/EGFR: a role in lung cancer?
1999 (Cycle VIII)
$40,436
University of California, San Francisco
Wen Shi
Ph.D.
8FT-0033
Membrane Signaling Pathways of RAS/RAB Proteins
1995 (Cycle IV)
$574,559
Scripps Research Institute
William Balch
Ph.D.
4RT-0222
Mentholated cigarettes and risk of acute MI, CHD, and stroke
2002 (Cycle XI)
$106,246
Kaiser Foundation Research Institute
Stephen Sidney
M.D.
11IT-0203
Methyl-DNA Binding Protein Regulation and Function
1999 (Cycle VIII)
$54,546
University of California, San Diego
Darren Casteel
8DT-0169
Micro RNA and dopamine-induced dentritic protein synthesis
2005 (Cycle XIV)
$59,000
California Institute of Technology
Hwan-Ching Tai
B.S.
14DT-0040
Mild carbon monoxide exposure impairs the inner ear
2005 (Cycle XIV)
$397,320
University of California, Los Angeles
Ivan Lopez
Ph.D.
14RT-0043H
Mitotic spindle checkpoint & chromosomal instability
2000 (Cycle IX)
$69,500
Ludwig Institute for Cancer Research
Zahid Bonday
Ph.D.
9FT-0207
Mobilized dendritic cells for lung cancer
2000 (Cycle IX)
$950,821
Stanford University
Edgar Engleman
M.D.
9RT-0229
Model for surveillance of CA tobacco control policies
2001 (Cycle X)
$325,761
Pacific Institute for Research and Evaluation
Harold Holder
Ph.D.
10RT-0102
Modeling cost/effectiveness of tobacco control programs
2002 (Cycle XI)
$129,915
University of California, San Diego
Robert Kaplan
Ph.D.
11RT-0243
Modeling cost/effectiveness of tobacco control programs
2002 (Cycle XI)
$23,238
University of California, Los Angeles
Robert Kaplan
Ph.D.
11RT-0243A
Modeling ETS Exposure and Dose Using PDA E-Diaries
2006 (Cycle XV)
$291,531
San Diego State University Research Foundation
Marilyn Johnson-Kozlow
Ph.D.
15KT-0175
Modeling sleep disturbance during nicotine withdrawal
2002 (Cycle XI)
$424,344
SRI International
Teresa Steininger
Ph.D.
11KT-0218
Modeling the relation of smoking to the ovarian function
1999 (Cycle VIII)
$53,448
University of California, Davis
Yan Liu
M.D.
8DT-0172
Modulating TLR9 Activation for Lung Cancer Therapy
2007 (Cycle XVI)
$762,411
Scripps Research Institute
Tsung-Hsien Chuang
Ph.D.
16RT-0103
Molecular Dynamics & Regulation of Apo A-I's Conformation
2007 (Cycle XVI)
$644,293
Children's Hospital Oakland Research Institute
Michael Oda
Ph.D.
16RT-0163
Molecular neurobiology of nicotine addiction
2001 (Cycle X)
$263,298
University of California, Los Angeles
Jim Boulter
Ph.D.
10RT-0136
Molecular origins of ApoB atherogenic lipoproteins
2000 (Cycle IX)
$445,617
University of California, San Francisco
Robert Hamilton
Ph.D.
9RT-0227
Molecular predictors of oral cancer development
2002 (Cycle XI)
$419,000
University of California, San Francisco
Richard Charles Jordan
D.D.S., Ph.D.
11RT-0141
Molecular targets for tobacco oxidants in lung cell death
2001 (Cycle X)
$70,000
University of California, Davis
Tommer Ravid
Ph.D.
10FT-0134
Monitoring exposure to tobacco-specific nitrosamines
1999 (Cycle VIII)
$74,999
University of California, Riverside
Thomas Morton
Ph.D.
8IT-0058
Motivational interviewing to prevent postpartum relapse
1997 (Cycle VI)
$282,502
Kaiser Foundation Research Institute
Virginia Quinn
MPH
6KT-0206
Motivation-enhanced teenage tobacco use cessation
1997 (Cycle VI)
$750,248
University of Southern California
Steve Sussman
Ph.D.
6RT-0182
Multibehavioral changes for disease prevention among smokers
2002 (Cycle XI)
$69,824
University of California, San Francisco
Judith Prochaska
Ph.D., M.P.H.
11FT-0013
Natural history of tobacco addiction in adolescents
1998 (Cycle VII)
$499,505
University of California, San Francisco
Anna-Barbara Moscicki
M.D.
7RT-0195
Negative effects of smoke on novel HDL mimetic therapies
2008 (Cycle XVII)
$661,125
Lawrence Berkeley National Laboratory
John Bielicki
Ph.D.
17RT-0082
Neural mechanisms underlying nicotine as a 'gateway' drug
2007 (Cycle XVI)
$60,000
University of California, Irvine
Susan McQuown
B.A.
16DT-0189
Neuroadaptations underlying nicotine dependence
2002 (Cycle XI)
$60,379
Scripps Research Institute
Adrie Bruijnzeel
Ph.D.
11FT-0112
Neurobehavioral consequences of adolescent nicotine exposure
2000 (Cycle IX)
$120,000
Scripps Research Institute
Cindy Ehlers
Ph.D.
9RT-0210
Neurobehavioral consequences of adolescent nicotine exposure
2001 (Cycle X)
$630,710
Scripps Research Institute
Cindy Ehlers
Ph.D.
10RT-0334
Neurobiological substrates of nicotine addiction
2003 (Cycle XII)
$723,613
Scripps Research Institute
Athina Markou
Ph.D.
12RT-0231
Neurobiological substrates of nicotine addiction
2006 (Cycle XV)
$419,503
University of California, San Diego
Athina Markou
Ph.D.
15RT-0022
Neurobiological substrates of nicotine addiction
1998 (Cycle VII)
$742,393
Scripps Research Institute
Athina Markou
Ph.D.
7RT-0004
Neurobiological substrates of nicotine addiction
2001 (Cycle X)
$402,852
Scripps Research Institute
Athina Markou
Ph.D.
10RT-0074
Neuroendocrine responses to nicotine: a physiologic probe
1998 (Cycle VII)
$225,000
University of California, San Francisco
Lori Karan
M.D.
7KT-0031
Neuronal nicotinic receptor trafficking in nicotine addictio
2001 (Cycle X)
$71,664
California Institute of Technology
Raad Nashmi
Ph.D.
10FT-0174
Neuronal oxidative stress from mild carbon monoxide exposure
2005 (Cycle XIV)
$418,972
University of California, Los Angeles
John Edmond
Ph.D.
14RT-0068
Neuropharmacology of nicotine relapse
2003 (Cycle XII)
$149,175
Cedars-Sinai Medical Center
Xiu Liu
M.D., Ph.D.
12KT-0188
Neurotoxic effects of nicotine: anatomy, mechanisms, effects
1999 (Cycle VIII)
$183,424
University of California, Los Angeles
Gaylord Ellison
Ph.D.
8RT-0005
Neurotransmitter systems and tobacco smoking
1999 (Cycle VIII)
$430,910
University of California, Los Angeles
Richard Olmstead
Ph.D.
8RT-0078H
New methods for searching tobacco industry documents
2003 (Cycle XII)
$59,551
University of California, San Francisco
Martha Michel
M.S.
12DT-0186
New therapy for lung cancer using radioiodide
2000 (Cycle IX)
$225,000
University of California, Los Angeles
Min Huang
M.D., M.S.
9KT-0215
Next Generation Califronai Tobacco Control Alliance
2003 (Cycle XII)
$3,890
Next Generation Alliance
Traci Verardo
12ST-0266
NF-kB mediated inflammation in tobacco-induced lung cancer
2006 (Cycle XV)
$420,000
University of California, San Diego
Michael Karin
Ph.D.
15RT-0197
Nicotine & behavioral regulation in adult ADHD
2005 (Cycle XIV)
$495,092
University of California, Irvine
Jean-G. Gehricke
Ph.D.
14RT-0147H
Nicotine & cardiac vulnerability to fibrillation
2000 (Cycle IX)
$120,000
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
9RT-0041
Nicotine & its metabolites: apoptosis in developing neurons
2000 (Cycle IX)
$412,200
Human BioMolecular Research Institute
Jun Zhang
Ph.D.
9KT-0228
Nicotine & Neuroendocrine Cell Signalling in Fetal Lung
1995 (Cycle IV)
$349,873
University of Southern California
Carol Wuenschell
Ph.D.
4KT-0339
Nicotine and cardiac vulnerability to fibrillation
2002 (Cycle XI)
$641,821
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
11RT-0058
Nicotine and cardiac vulnerability to fibrillation
1997 (Cycle VI)
$370,057
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
6RT-0020
Nicotine and congenital heart disease
2008 (Cycle XVII)
$629,797
Stanford University
Ching-Pin Chang
M.D., PH.D
17RT-0102
Nicotine and Smoking Effects on Neuromuscular Development
1995 (Cycle IV)
$412,639
Cedars-Sinai Medical Center
Mario Fournier
Ph.D.
4RT-0132
Nicotine dependence & schizophrenia
2001 (Cycle X)
$75,600
Scripps Research Institute
Svetlana Semenova
Ph.D.
10FT-0323
Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally
2006 (Cycle XV)
$133,126
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
15IT-0250
Nicotine effects on gene expression and metaplasticity
2004 (Cycle XIII)
$74,500
Stanford University
Damian Wheeler
B.SC., Ph.D.
13FT-0059
Nicotine effects on neurological development
1999 (Cycle VIII)
$189,233
University of California, Irvine
Raju Metherate
Ph.D.
8RT-0059
Nicotine effects on renal function in experimental diabetes
2000 (Cycle IX)
$98,313
University of California, San Diego
Francis Gabbai
M.D.
9RT-0169
Nicotine in the Brain
2000 (Cycle IX)
$518,966
University of California, San Diego
Darwin Berg
Ph.D.
9RT-0221
Nicotine May Affect Inflammation
1999 (Cycle VIII)
$435,425
University of California, San Francisco
Frederick Jia-Pei Miao
M.D., Ph.D.
8RT-0032
Nicotine Metabolism in Families
1998 (Cycle VII)
$465,537
University of California, San Francisco
Neal Benowitz
M.D.
7PT-2004
Nicotine modifies cardiac growth during adolescence
2007 (Cycle XVI)
$138,600
Veterans Medical Research Foundation
Wilbur Lew
M.D.
16IT-0007
Nicotine pharmacogenetics: influence of ethnicity
1997 (Cycle VI)
$242,344
Cedars-Sinai Medical Center
Russell Poland
Ph.D.
6RT-0069A
Nicotine pharmacogenetics: influence of ethnicity
1997 (Cycle VI)
$366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Russell Poland
Ph.D.
6RT-0069
Nicotine Receptors: Role in Nicotine Addiction
2006 (Cycle XV)
$20,748
California Institute of Technology
Ryan Drenan
Ph.D.
15FT-0030
Nicotine recp mediated dopamine release and chronic nicotine
2006 (Cycle XV)
$75,000
The Parkinson's Institute
Xiomara Perez
Ph.D.
15FT-0073
Nicotine regulates cardiac toxicity with lipopolysaccharide
2000 (Cycle IX)
$100,000
University of California, San Diego
Wilbur Lew
M.D.
9RT-0166
Nicotine regulation of the noradrenergic system
2000 (Cycle IX)
$52,375
University of California, Irvine
Kathryn O'Leary
M.S., Ph.D.
9DT-0115
Nicotine replacement in school-based cessation
2000 (Cycle IX)
$961,266
University of Southern California
Clyde Dent
Ph.D.
9HT-3201
Nicotine replacement in school-based cessation
2000 (Cycle IX)
$961,266
University of Southern California
Rita Leeseman
9HT-3201
Nicotine replacement therapy: pharmacists' counseling role
1998 (Cycle VII)
$113,929
SRI International
Karen Hudmon
Dr.P.H., R.P.H., M.S.
7IT-0169
Nicotine self-administration in an animal model
2003 (Cycle XII)
$660,156
Scripps Research Institute
George Koob
Ph.D.
12RT-0099
Nicotine Self-Administration in an Animal Model
2008 (Cycle XVII)
$720,434
Scripps Research Institute
George Koob
Ph.D.
17RT-0095
Nicotine synapse formation in the hippocampus
2005 (Cycle XIV)
$59,500
University of California, San Diego
Kerri Massey
B.A.
14DT-0029
Nicotine toxicity acting on cardiac neurons
1997 (Cycle VI)
$446,920
University of California, San Diego
Darwin Berg
Ph.D.
6RT-0050
Nicotine withdrawal, smoking & attention: an fMRI study
2001 (Cycle X)
$515,303
University of California, Los Angeles
Edythe London
Ph.D.
10RT-0091H
Nicotine-dependent recruitment of vascular progenitor cells
2006 (Cycle XV)
$799,907
The Burnham Institute for Medical Research
William Stallcup
Ph.D.
15RT-0034
Nicotine-pathological angiogenesis and genetic determinants
2002 (Cycle XI)
$608,420
Stanford University
John Cooke
M.D., Ph.D.
11RT-0147
Nicotine's effects on uterine artery contractillity
2005 (Cycle XIV)
$73,878
Loma Linda University
DaLiao Xiao
Ph.D.
14FT-0075
Nicotinic and Schizophrenia
2000 (Cycle IX)
$87,719
University of California, Irvine
Ricardo Miledi
M.D.
9RT-0173
Nicotinic Manipulation of the Hippocampus
2007 (Cycle XVI)
$420,000
University of California, San Diego
Darwin Berg
Ph.D.
16RT-0167
Nicotinic modulation of dopamine release during development
1999 (Cycle VIII)
$25,698
University of California, Irvine
Layla Azam
8DT-0168
Nicotinic receptors & synaptic aging
2001 (Cycle X)
$224,973
University of California, San Diego
Jay Coggan
Ph.D.
10KT-0082
Nicotinic receptors and Parkinson's disease
2002 (Cycle XI)
$376,470
The Parkinson's Institute
Maryka Quik
Ph.D.
11RT-0216
Nicotinic receptors at GABAergic synapses in the hippocampus
2004 (Cycle XIII)
$75,000
University of California, San Diego
Jingming Zhang
Ph.D.
13FT-0005
Nicotinic receptors in nicotine addiction
2008 (Cycle XVII)
$634,779
California Institute of Technology
Henry Lester
Ph.D.
17RT-0127
Nicotinic receptors on hippocampal neurons
2002 (Cycle XI)
$69,940
University of California, San Diego
Wagner Zago
Ph.D.
11FT-0099
Nicotinic receptors, smoking and Parkinson's Disease
2002 (Cycle XI)
$765,971
Stanford University
Lorene Nelson
Ph.D.
11RT-0237
Nicotinic Regulation of GABAergic Inhibition/Excitation
2008 (Cycle XVII)
$75,000
University of California, San Diego
Natalia Gounko
Ph.D.
17FT-0053
Nicotinic Regulation of GABAergic Signaling
2006 (Cycle XV)
$70,120
University of California, San Diego
Zhaoping Liu
Ph.D.
15KT-0157
Nicotinic Regulation of Neurogenesis in Adult Hippocampus
2008 (Cycle XVII)
$60,000
University of California, San Diego
Nolan Campbell
B.S. Biology
17DT-0191
Nicotonic receptors: role in addiction and reproduction
1997 (Cycle VI)
$437,480
Salk Institute for Biological Studies
Stephen Heinemann
Ph.D.
6RT-0055
Nitric oxide-dependent cell signaling in vascular cells
2000 (Cycle IX)
$149,557
University of California, San Diego
Tanima Gudi
Ph.D.
9KT-0170H
Nitrogen Oxides and cigarette smoke-induced injury
1998 (Cycle VII)
$304,118
University of California, Davis
Albert van der Vliet
Ph.D.
7RT-0167
NMR studies of the LDL receptor active conformation of ApoE
2007 (Cycle XVI)
$60,000
University of California, Berkeley
Paul Hauser
B.S.
16DT-0195
NMR Study of 13C Edatrexate Metabolism
1995 (Cycle IV)
$258,990
University of California, Davis
Thomas Jue
Ph.D.
4RT-0373
Noninvasive imaging of early atherosclerosis
1997 (Cycle VI)
$101,923
University of California, San Diego
Sotirios Tsimikas
M.D.
6KT-0100
Nonsmokers helping smokers and the role of culture
2004 (Cycle XIII)
$476,656
University of California, San Diego
Shu-Hong Zhu
Ph.D.
13RT-0023
Novel agents for apoptosis of lung cancer
2002 (Cycle XI)
$787,977
The Burnham Institute for Medical Research
Xiao-Kun Zhang
Ph.D.
11RT-0081
Novel Approaches to Lung Cancer Research
2006 (Cycle XV)
$189,486
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
15IT-0021
Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment
2007 (Cycle XVI)
$75,000
University of California, Irvine
Lai Chu Lin
Ph.D.
16FT-0058
Novel DNA vaccines for the treatment of lung cancer
2000 (Cycle IX)
$1,063,300
Scripps Research Institute
Ralph Reisfeld
Ph.D.
9RT-0017
Novel DNA vaccines for the treatment of lung cancer
2003 (Cycle XII)
$783,900
Scripps Research Institute
Ralph Reisfeld
Ph.D.
12RT-0002
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer
2008 (Cycle XVII)
$394,380
University of California, San Francisco
Steven Rosen
Ph.D.
17RT-0117
Novel imaging methods for diagnosing tobacco related cancers
1997 (Cycle VI)
$629,087
Stanford University
Albert Macovski
Ph.D.
6RT-0384
Novel nicotine cessation therapeutics
2000 (Cycle IX)
$802,840
Human BioMolecular Research Institute
John Cashman
Ph.D.
9RT-0196H
Novel Office-Based Device for Imaging Vocal Cord Cancer
2003 (Cycle XII)
$510,000
University of California, Irvine
Brian Wong
M.D., Ph.D.
12RT-0113
Novel regulatory mechanisms for lung cancer growth
2000 (Cycle IX)
$100,000
University of California, San Diego
Randolph Hastings
M.D., Ph.D.
9RT-0037
Novel regulatory mechanisms for lung cancer growth
2001 (Cycle X)
$620,032
Veterans Medical Research Foundation
Randolph Hastings
M.D., Ph.D.
10RT-0161H
Novel strategy for protecting neurons from injury in stroke
1999 (Cycle VIII)
$742,809
Stanford University
Robert Sapolsky
Ph.D.
8RT-0073
Novel therapy for pancreatic cancer
1997 (Cycle VI)
$452,332
University of California, Irvine
Hung Fan
Ph.D.
6RT-0266
NRT and paroxetine for smoking cessation
1997 (Cycle VI)
$646,916
Stanford University
Joel Killen
Ph.D.
6RT-0041
Oral clefts, smoking & variation of toxin biotransformation
2004 (Cycle XIII)
$623,472
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
13RT-0109
Oral clefts, smoking & variation toxin biotransformation
1997 (Cycle VI)
$677,128
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
6RT-0360
Overcoming drug resistance in small cell lung cancer
2001 (Cycle X)
$141,340
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
10IT-0246
Oxidative damage to sperm DNA: smoking and diet interaction
1998 (Cycle VII)
$155,135
University of California, Berkeley
Bruce Ames
Ph.D.
7RT-0178
Oxidative damage to sperm DNA: smoking and diet interaction
1998 (Cycle VII)
$132,367
Children's Hospital Oakland Research Institute
Bruce Ames
Ph.D.
7RT-0178A
Oxidative stress and skeletal muscle dysfunction in COPD
2006 (Cycle XV)
$555,000
University of California, San Diego
Russell Richardson
Ph.D.
15RT-0100H
Oxidized lipids and programmed cell death in atherosclerosis
1999 (Cycle VIII)
$69,116
University of California, San Diego
Mi-Kyung Chang
M.D.
8FT-0101
Oxygen Club of California
2007 (Cycle XVI)
$5,000
Oxygen Club
John Maguire
DDS
16ST-0218
Oxygen Club of California
2003 (Cycle XII)
$5,000
Oxygen Club
John Maguire
DDS
12ST-0267
Oxygen Club of California
2005 (Cycle XIV)
$5,000
Oxygen Club
John Maguire
DDS
14ST-0193
Oxygen radicals in biology GRC 2006
2005 (Cycle XIV)
$5,000
University of California, Merced
Henry Forman
Ph.D.
14ST-0191
Oxygen Radicals in Biology GRC2008
2007 (Cycle XVI)
$5,000
University of Southern California
Enrique Cadenas
Ph.D.
16ST-0216
Oxygen Transport Following Lung Transplantation in COPD
2007 (Cycle XVI)
$74,500
University of California, San Diego
Moh Malek
Ph.D.
16FT-0060
Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation
2007 (Cycle XVI)
$260,203
University of California, Davis
Ayala Luria
Ph.D.
16KT-0037
p53 and p14ARF: Multiple pathways of lung cancer suppression
2002 (Cycle XI)
$821,050
Sidney Kimmel Cancer Center
Ruth Gjerset
Ph.D.
11RT-0074
p53 Mutations in Sporadic & Familial Childhood Tumors
1994 (Cycle III)
$213,407
University of California, Davis
Sara Bodner
M.D.
3KT-0400A
Pager-assisted smoking cessation treatment
2002 (Cycle XI)
$463,689
University of California, San Francisco
Timothy Carmody
Ph.D.
11RT-0009
Pager-cued therapeutic messages for smoking cessation
1999 (Cycle VIII)
$74,889
University of California, San Francisco
Timothy Carmody
Ph.D.
8IT-0053A
Parental and Movie Influences on Adolescent Smoking Behavior
1999 (Cycle VIII)
$50,793
University of California, San Diego
Janet Distefan
Ph.D.
8DT-0167
Parkinson's Disease: A Protective Effect of Smoking?
1999 (Cycle VIII)
$512,849
Stanford University
Lorene Nelson
Ph.D.
8RT-0131